
    
      The aim was amended in February 2016--because of the unexpected unavailability of the
      original high-dose formulation of amoxicillin/clavulanate--to compare the effectiveness
      (versus standard dose) of extended-release (the original formulation) versus
      immediate-release amoxicillin/clavulanate.
    
  